Massachusetts · Bill 1222 · 194th General Court
An Act relative to prescription medication re-authorization
- Introduced Feb 27, 2025
- In committee Feb 27, 2025
- Passed the House Next
- Passed the Senate
- To the governor
- Became law
What it does
The legislature's own summary of the bill, or its official long title.
By Representative Kerans of Danvers, a petition (accompanied by bill, House, No. 1222) of Sally P. Kerans relative to prohibiting insurers from requiring annual re-authorizations for certain prescription drugs. Financial Services.
Every action
7 steps, oldest first, as the legislature records them.
- CommitteeReferred to the committee on Financial Services · Joint Committee on Financial Services
- SenateSenate concurred
- CommitteeHearing scheduled for 06/10/2025 from 10:30 AM-01:00 PM in A-2 · Joint Committee on Financial Services
- CommitteeReported favorably by committee and referred to the committee on Health Care Financing · Joint Committee on Health Care Financing
- HouseReporting date extended to Wednesday, March 18, 2026
- HouseReporting date extended to Monday, June 15, 2026
- HouseReporting date extended to Friday, July 31, 2026
Roll calls
1 recorded vote: 0 on the floor, 1 in committee. Each shows how every member voted.
Committee votes
| Date | Where | Question | Result |
|---|---|---|---|
| Sep 8, 2025 | Joint Committee on Financial Services | Committee report: Favorable (Favorable report on pharmacy matters) | 11–0 |
Sponsors
The member who introduced it.
-
Sally P. KeransD Primary sponsor · District 13th Essex
From Massachusetts's official records (malegislature.gov/api), checked Nov 19, 2026. Text links go to the official versions; LegiList does not copy bill text.